Products for Research Use Only

KRASG12C IN-18

CAT: 0013-GTR19274073-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19274073-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KRASG12C IN-18 is an orally active covalent inhibitor of KRASG12C, achieving complete covalent binding to KRASG12C in both GDP- and GMPPNP-bound states. It exhibits significant antiproliferative activity against KRASG12C and its resistant mutations (including KRASG12C/R68S) with an IC50 in the low nanomolar range. KRASG12C IN-18 demonstrates notable in vivo efficacy in KRASG12C-driven solid tumors and KRASG12C/R68S xenograft models, making it applicable for colorectal adenocarcinoma research.
CAS Number
2966924-24-1
Smiles
C (OC=1N=C (C2=C (N1) C (F) =C (C (F) =C2) C=3C4=C (C=CC3) C=CC (F) =C4C#C) N5C[C@H] (CC#N) N (C (C (=C) F) =O) CC5) C67N (CCC6) CCC7
Molecular Formula
C37H32F4N6O2
Molecular Weight
668.7
Storage Conditions
-20°C
Notes
For research use only.